Literature DB >> 29777892

Surgically Treated de Novo Cervicomedullary Arachnoid Cyst in Symptomatic Adult Patient.

William Clifton1, Gazanfar Rahmathulla2, Kourosh Tavanaiepour2, Dunbar Alcindor2, George Jakubek3, Daryoush Tavanaiepour2.   

Abstract

BACKGROUND: Arachnoid cysts are a relatively common finding in adult patients, especially with the advent of advanced imaging techniques. The overall incidence ranges from 1%-2%, and the majority are clinically silent. Arachnoid cysts are postulated to arise by congenital anomalies or trauma. De novo formation of arachnoid cysts has been reported but is exceptionally rare and mostly found in the pediatric population after head trauma. There have only been 2 reported cases of symptomatic de novo arachnoid cyst formation in adult patients to date, both with histories of head trauma. CASE DESCRIPTION: We present a case of a 71-year-old male patient with progressive vertigo who had previous brain magnetic resonance imaging studies without abnormalities. Another MRI was performed 3 years from the last study that showed interval development of a large cystic lesion compressing the right cervicomedullary junction, as well as radiologic evidence of neurosarcoidosis. Intraoperative findings showed a cystic mass with clear, gelatinous fluid. The cyst was drained, and the walls were resected and sent to pathology. Histopathologic testing confirmed the lesion was an arachnoid cyst. The patient's vertiginous symptoms improved after surgery.
CONCLUSIONS: This case represents the first incidence of a pathology-proven, nontraumatic de novo arachnoid cyst.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Arachnoid cyst; Sarcoidosis; Vertigo

Mesh:

Year:  2018        PMID: 29777892     DOI: 10.1016/j.wneu.2018.05.046

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  1 in total

1.  Intraparenchymal hemorrhage after surgical decompression of an epencephalon arachnoid cyst: A case report.

Authors:  Xue-Jian Wang
Journal:  World J Clin Cases       Date:  2021-01-06       Impact factor: 1.337

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.